Literature DB >> 216488

Inhibition of human lymphocyte mitogen and antigen response by a 15,000-dalton protein from feline leukemia virus.

L C Hebebrand, R G Olsen, L E Mathes, W S Nichols.   

Abstract

Peripheral blood lymphocyte response of normal human subjects to mitogens and antigens was suppressed by a 15,000-dalton protein (p15) from a C-type feline leukemia virus. Four of six subjects were suppressed 70 to 96% when responding to concanavalin A or phytohemagglutinin in the presence of 5.0 microgram of p15. The three subjects who responded to streptokinase-streptodornase and Candida were suppressed 68 to 91% when cultured with 5.0 microgram of p15. The subviral protein did not appear to be cytotoxic at doses reported. Lymphocyte membrane studies with fluorescein isothiocyanate-concanavalin A revealed a reduction in concanavalin A-induced cap formation of 51 to 91% in the presence of the same dose of p15. These results demonstrate that in vitro immunological dysfunction in human lymphocytes can be induced by a C-type virion protein.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 216488

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

Review 1.  Feline leukemia virus: current status of the feline induced immune depression and immunoprevention.

Authors:  R G Olsen; M G Lewis; L J Lafrado; L E Mathes; K Haffer; R Sharpee
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  Sequence variation of human endogenous retrovirus ERV9-related elements in an env region corresponding to an immunosuppressive peptide: transcription in normal and neoplastic cells.

Authors:  M Lindeskog; P Medstrand; J Blomberg
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

3.  Animal model of human disease: leukemic lymphoma.

Authors:  R G Olsen; L E Mathes; L C Hebebrand; E A Hoover; W S Nichols
Journal:  Am J Pathol       Date:  1980-03       Impact factor: 4.307

Review 4.  Endogenous env elements: partners in generation of pathogenic feline leukemia viruses.

Authors:  P Roy-Burman
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

5.  Permanent inhibition of capping of spleen lymphocytes from neonatally oestrogen-treated female mice.

Authors:  T Kalland; J G Forsberg
Journal:  Immunology       Date:  1980-02       Impact factor: 7.397

6.  Mutations within the env gene of Mason-Pfizer monkey virus: effects on protein transport and SU-TM association.

Authors:  B A Brody; E Hunter
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

7.  Broadening the use of antiretroviral therapy: the case for feline leukemia virus.

Authors:  Willie M Greggs; Christine L Clouser; Steven E Patterson; Louis M Mansky
Journal:  Ther Clin Risk Manag       Date:  2011-03-16       Impact factor: 2.423

Review 8.  Feline leukemia/sarcoma viruses and immunodeficiency.

Authors:  J Rojko; M Essex; Z Trainin
Journal:  Adv Vet Sci Comp Med       Date:  1988

9.  Human malignant and mitogen-transformed cells contain retroviral P15E-related antigen.

Authors:  G J Cianciolo; D Phipps; R Snyderman
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

10.  Anti-inflammatory effect of a retrovirus-derived immunosuppressive peptide in mouse models.

Authors:  Martin Tolstrup; Claus Johansen; Lars Toft; Finn S Pedersen; Anne Funding; Shervin Bahrami; Lars Iversen; Lars Østergaard; Mogens Duch
Journal:  BMC Immunol       Date:  2013-11-18       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.